Literature DB >> 8542113

Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.

A Günther1, C Siebert, R Schmidt, S Ziegler, F Grimminger, M Yabut, B Temmesfeld, D Walmrath, H Morr, W Seeger.   

Abstract

Bronchoalveolar lavage fluids (BALF) were analyzed for surfactant abnormalities in 153 patients with acute respiratory failure necessitating mechanical ventilation. Diagnoses were acute respiratory distress syndrome (ARDS) in the absence of lung infection (n = 16), severe pneumonia (PNEU; n = 88), ARDS and PNEU (n = 36), and cardiogenic lung edema (CLE; n = 13). The PNEU group was subdivided into groups with alveolar PNEU (n = 35), bronchial PNEU (n = 16), interstitial PNEU (n = 18) and nonclassified PNEU (n = 19). Comparison with healthy controls (n = 20) was undertaken. Total phospholipids (PL), proteins, PL classes (HPTLC) and surfactant apoproteins SP-A and SP-B (ELISA) were quantified in the original BALF. The 48,000 x g pellet from centrifugation of the BAL was used to assess the percentage of large surfactant aggregates (LSA) and the biophysical properties of the surfactant (pulsating bubble surfactometer). All groups with inflammatory lung injury (PNEU and/or ARDS) showed some decrease in the lavageable PL pool, a reduced LSA content in BALF, and a manifold increase in alveolar protein load. Marked changes in the PL profile were noted throughout the groups (a decrease in phosphatidylcholine (PC) and phosphatidylglycerol (PG) and an increase in phosphatidylinositol [PI] and sphingomyelin [SPH]). Concentrations of SP-A but not of SP-B in BALF were reduced. Minimum surface-tension values approached 0 mN/m in controls, and ranged from 10 to 25 mN/m in the absence of supernatant protein and from 20 to 35 mN/m in recombination with leaked protein in the groups with ARDS and/or PNEU. Abnormalities in alveolar PNEU surpassed those in bronchial PNEU, and interstitial PNEU presented a distinct pattern with extensive metabolic changes. All surfactant changes were absent in CLE except for a slight inhibition of surface activity by proteins. We conclude that pronounced surfactant abnormalities, comparable to those in ARDS in the absence of lung infection, occur in different entities of severe PNEU, but not in CLE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8542113     DOI: 10.1164/ajrccm.153.1.8542113

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  90 in total

Review 1.  Homeostasis and its disruption in the lung microbiome.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-02       Impact factor: 5.464

Review 2.  The microbiome and critical illness.

Authors:  Robert P Dickson
Journal:  Lancet Respir Med       Date:  2015-12-12       Impact factor: 30.700

3.  Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems.

Authors:  Dongeun Huh; Hideki Fujioka; Yi-Chung Tung; Nobuyuki Futai; Robert Paine; James B Grotberg; Shuichi Takayama
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-15       Impact factor: 11.205

Review 4.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

5.  Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae.

Authors:  A van't Veen; J W Mouton; D Gommers; B Lachmann
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

6.  Tracheal acid or surfactant instillation raises alveolar surface tension.

Authors:  Tam L Nguyen; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2018-05-17

7.  Surface tension in situ in flooded alveolus unaltered by albumin.

Authors:  Angana Banerjee Kharge; You Wu; Carrie E Perlman
Journal:  J Appl Physiol (1985)       Date:  2014-06-26

8.  Cap-independent translation of human SP-A 5'-UTR variants: a double-loop structure and cis-element contribution.

Authors:  Guirong Wang; Xiaoxuan Guo; Patricia Silveyra; Scot R Kimball; Joanna Floros
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-01-30       Impact factor: 5.464

9.  Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.

Authors:  Philipp Markart; Clemens Ruppert; Malgorzata Wygrecka; Thorsten Colaris; Bhola Dahal; Dieter Walmrath; Heinz Harbach; Jochen Wilhelm; Werner Seeger; Reinhold Schmidt; Andreas Guenther
Journal:  Thorax       Date:  2007-02-07       Impact factor: 9.139

Review 10.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.